reports
EQS-News: Batteriekühlsysteme für neue E-Busse: technotrans sichert si...
EQS-News: technotrans SE / Schlagwort(e): Sonstiges Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag 21.05.2024 / 13:57 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag Großvolumenauftrag im hohen einstelligen Millionen-Euro-Bereich Serienfertigung von Batterie-Thermomanagement-Systemen (BTMS) für mehrere E-Bus-Serien Wachstumsbeschleuniger im technotrans-Fokusmarkt Energy Management und Meilenstein im Segment Straßenfahrzeuge Sassen...
EQS-News: Battery cooling systems for new e-buses: technotrans secures...
EQS-News: technotrans SE / Key word(s): Miscellaneous Battery cooling systems for new e-buses: technotrans secures major order 21.05.2024 / 13:57 CET/CEST The issuer is solely responsible for the content of this announcement. Battery cooling systems for new e-buses: technotrans secures major order Large-volume order in the high single-digit million euro range Series production of battery thermal management systems (BTMS) for several e-bus series Growth accelerator in technotrans' focus market Energy Management and milestone in the road vehicles segment Sassenberg, 21 M...
Alvotech and Dr. Reddy’s enter into collaboration for commercializatio...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)Alvotech will be responsible for development and manufacture of the product HYDERABAD, INDIA & REYKJAVIK, ICELAND — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Red...
Alvotech gengur til samstarfs við Dr. Reddy‘s um markaðssetningu AVT03...
Alvotech gengur til samstarfs við Dr. Reddy‘s um markaðssetningu AVT03, fyrirhugaðrar hliðstæðu við Prolia og Xgeva, í Bandaríkjunum og Evrópu Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hefði gert samstarfssamning við Dr. Reddy’s Laboratories SA, dótturfyrirtæki Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) um sölu- og markaðssetningu AVT03, fyrirhugaðrar líftæknilyfjahliðstæðu Alvotech við Prolia og Xgeva, sem bæði innnihalda denosumab. Dr. Reddy er alþjóðlegt lyfjafyrirtæki með höfuðstöðvar á Indlandi en starfsemi um allan heim. Prolia og Xgeva eru líftæknilyf við ýmsum þr...
KANZHUN LIMITED Announces Board Changes
KANZHUN LIMITED Announces Board Changes BEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Shangyu Gao has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on May 21, 2024. In addition, with effect from May 21, 2024, Ms. Mengyuan Dong has been appointed as an independent non-executive director of the Company, the chairman of the audit committee, a member...
Alarum Announces Q1 2024 Results
Alarum Announces Q1 2024 Results First quarter record revenues of $8.4 Million, up 47% year over year; IFRS gross margin climbed to 78% compared to 66% for the first quarter of last year IFRS net profit was $1.4 million while non-IFRS net profit surged to $2.8 million; Earnings per American Depository Share (EPS) of $0.23 and $0.45, respectively Adjusted EBITDA reached a record of $3.2 million Subsidiary NetNut’s revenues in the first quarter jumped 139% year over year; Net Retention Rate (“NRR”) increased to 1.66 TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- (N...
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power...
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip New Product Provides Engineers with Greater Flexibility in Designing for Higher Power Output in EV Chargers MANCHESTER, N.H., May 21, 2024 (GLOBE NEWSWIRE) -- (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the launch of the third product in its High Voltage Power-Thru™ portfolio. Allegro’s two-chip isolated gate-driver IC solutions work together with external transformers to provide the freedom to design and...
Alvotech and Dr. Reddy’s enter into collaboration for commercializatio...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product HYDERABAD, India and REYKJAVIK, Iceland, May 21, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines fo...
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA. Event: TD Cowen’s 5th Annual Oncology Innovation SummitDate: Tuesday, May 28, 2024Time: 8:30 AM EDTLocation: Virtual The presentation will be webcast live and available for replay under “Events & Presentations” in the Investors section of the Co...
Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Con...
Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Conference SECAUCUS, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the Deutsche Bank Global Consumer Conference in Paris, France. The presentation will be on Tuesday, June 4, 2024 at 12:00 p.m. CEST / 6:00 a.m. EDT. A live webcast and replay will be available on the "Investors" section of the Company's website at . About Freshpet Freshpet’s mission is to improve the lives of dogs and ca...
Reviva to Participate in the BIO International Convention
Reviva to Participate in the BIO International Convention CUPERTINO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a panel discussion at the BIO International Convention, taking place June 3-6, 2024, in San Diego, CA. BIO Inte...
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVE...
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials Primary physician research found high level of interest in Tonmya as a potential new treatment option for fibromyalgia Significant dissatisfaction reported with drugs currently approved by FDA for the treatment of fibromyalgia Analysis of claims data rev...
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α...
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells -α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclonal Antibody Activity- -Preclinical Findings Presented at Digestive Disease Week 2024- WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced the...
Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarsh...
Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced Carrie Gordon, a sophomore at Drexel University, as the third recipient of its Tachi Yamada Scholarship award. The scholarship honors the legacy of Dr. Tachi Yamada, co-founder and former Chairman of the Passage Bio Board of Directors and is open to students enrolled in life sciences programs at fo...
Tempest to Participate in Upcoming Investor Conferences
Tempest to Participate in Upcoming Investor Conferences BRISBANE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that management will participate in the following upcoming investor conferences: TD Cowen's 5th Annual Oncology Innovation Summit – Fireside chat on Wednesday, May 29, 2024 at 2:00 p.m. ET Jefferies Global Healthcare Conference – Presentation on Wednesday, June 5, 2024 at 4:00 p.m. ET To access the l...
NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highl...
NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib’s Impact on Key Risk Factors for Cardiovascular Disease at Upcoming Medical Meetings -- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers -- -- On track to report topline data from Phase 3 BROOKLYN trial in HeFH in 3Q 2024 and Phase 3 BROADWAY trial in ASCVD in 4Q 2024 -- NAARDEN, the Netherlands and MIAMI, May 21, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS o...
ABM Expands Industry-leading EV Infrastructure Capabilities to Service...
ABM Expands Industry-leading EV Infrastructure Capabilities to Service Fleets Across the Private and Public Sectors Amid sustained EV industry growth, ABM’s turnkey eMobility solutions for fleet electrification to be showcased at ACT Expo May 20 to 23 NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- , a leading provider of integrated facility services, infrastructure solutions, and parking management is expanding its capabilities and focus to serve comprehensive fleet electrification, as eCommerce, distribution, last mile, airports, stadiums, municipal and public transit clients seek to scal...
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative...
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A Mooresville, NC, May 21, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF, FGFPP) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”), for the period commencing on March 15, 2024, and ending on June 14, 2024. In accordance with the terms of the Preferred Stock, the board of directors of the Company declared a ...
Kandi 10K All-Electric UTV Model Achieves EU EEC Certification
Kandi 10K All-Electric UTV Model Achieves EU EEC Certification JINHUA, CHINA, May 21, 2024 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (“Kandi” or the “Company”), a leading distributor of all-electric personal transportation and utility vehicles, today announced the certification of its 10K all-electric UTV model by the European Economic Community (EEC). This achievement confirms that the product meets the European Union's high standards for safety, quality, and performance, preparing it for its market debut within the EU. 10K All-Electric UTV ...
AGBA/Triller $4bn Merger: Excellent Progress Ahead of Plan
AGBA/Triller $4bn Merger: Excellent Progress Ahead of Plan LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), AGBA reports that on May 16, 2024, Triller Corp delivered to its stockholders a notice pursuant to Section 228(e) of the Delaware General Corporation Law, laying out specific details of the proposed merger between Triller and AGBA. The AGBA/Triller merger was approved on April 16, 2024, by written consent of stockholders holding over 63% of Triller’s voting common stock. Triller also reported that on ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.